Loading...
XIDX
PEHA
Market cap16mUSD
Nov 12, Last price  
326.00IDR
Name

Phapros Tbk PT

Chart & Performance

D1W1MN
XIDX:PEHA chart
P/E
—
P/S
0.37
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-7.60%
Revenues
744.69b
-26.57%
470,666,486,000529,752,573,000521,610,950,000578,139,346,000691,246,741,000816,132,595,0001,002,126,037,0001,022,969,624,0001,105,420,197,000980,556,653,0001,051,444,342,0001,168,474,434,0001,014,129,711,000744,694,626,000
Net income
-285.07b
L
64,696,441,00069,159,968,00042,105,371,00045,326,940,00063,007,926,00087,002,410,000125,266,061,000132,306,708,000102,033,530,00048,487,862,00011,070,907,00028,069,871,0005,959,329,000-285,069,165,000
CFO
141.28b
P
0019,500,898,00084,042,617,00070,089,895,000114,082,652,000102,026,324,000-75,906,305,000-2,481,802,000259,484,562,000189,923,155,00028,069,871,000-14,443,738,000141,277,659,000
Dividend
Jun 19, 202313.37 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. PT Phapros, Tbk also exports its products internationally. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk.
URL
https://www.phapros.co.id/
IPO date
Dec 26, 2018
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT